XLON
LLOY
Market cap87bUSD
Sep 17, Last price
112.20GBP
1D
0.85%
1Q
6.76%
Jan 2017
79.49%
Name
Lloyds Banking Group PLC
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Headquartered in London, UK, Lloyds Banking Group plc stands as a prominent financial services institution offering a comprehensive suite of banking and financial solutions across the United Kingdom. Its operations are strategically organised into three core divisions: Retail, Commercial Banking, and Insurance and Wealth. The Retail division caters to both individual consumers and small businesses, providing an extensive range of financial products, including current and savings accounts, home loans, vehicle finance, unsecured personal loans, various leasing arrangements, and credit cards. Through its Commercial Banking segment, the group supports small and medium-sized enterprises (SMEs), larger corporate entities, and other financial institutions, delivering services such as lending facilities, transactional banking, working capital management, risk mitigation, and expertise in debt financing and capital markets. The Insurance and Wealth segment focuses on delivering a diverse portfolio of insurance, investment, and wealth management products and services. Furthermore, the company embraces digital innovation by offering its services through various online banking platforms. Lloyds Banking Group distributes its offerings under several well-recognised brands, notably Lloyds Bank, Halifax, Bank of Scotland, and Scottish Widows. The institution boasts a long and distinguished history, having been established in 1695.
Related entities
Subsidiaries (346)
BANK OF SCOTLAND BRANCH NOMINEES LIMITED
BANK OF SCOTLAND CENTRAL NOMINEES LIMITED
BERGAMOT VENTURES LIMITED
BOS (USA) FUND INVESTMENTS INC.
BOS (USA) INC.
CANCARA ASSET SECURITISATION LIMITED
CITRA DEVELOPMENT COMPANY (NO.1) LIMITED
CITRA LIVING LIMITED
CITRA LIVING OPERATING COMPANY (NO. 1) LIMITED
CITRA LIVING PROPERTIES (NO. 1) LIMITED
CITRA LIVING PROPERTIES (NO. 6) LIMITED
CITRA LIVING PROPERTIES (NO.2) LIMITED
CITRA PATHWAYS LIMITED
CITY & GENERAL SECURITIES LIMITED
CLERICAL MEDICAL FINANCE LIMITED
CLERICAL MEDICAL INTERNATIONAL HOLDINGS B.V.
CLERICAL MEDICAL INVESTMENT FUND MANAGERS LIMITED
CLOAK LANE INVESTMENTS SARL
EUROPA PROPERTY COMPANY (NORTHERN) LIMITED
GRESHAM RECEIVABLES (N0.3) LIMITED
Key people
Norman Blackwell
Non-Executive Chairman of the Board · since 2014
Non-Executive Deputy Chairman of the Board, Senior Independent Director · since 2020
Antonio Lorenzo
Interim Chief Executive, Scottish Widows and Group Director, Insurance · since 2015
John Chambers
Group Chief Information Officer · since 2018
Kate Cheetham
Group General Counsel, Group Company Secretary · since 2019
William Chalmers
Chief Financial Officer, Executive Director · since 2019
Carla A. S. Antunes Da Silva
Group Strategy, Corporate Ventures and Investor Relations Director · since 2018
Paul Day
Chief Internal Auditor
Vim Maru
Group Director, Retail · since 2017
Group Director, Commercial Banking · since 2017
Jakob Pfaudler
Group Director, Community Banking · since 2017
Stephen Shelley
Group Chief Risk Officer · since 2017
Andrew Walton
Group Corporate Affairs Director · since 2018
Non-Executive Director · since 2020
Non-Executive Independent Director · since 2012
IPO date
Oct 08, 1986
Employees
59,354
Domiciled in
GB
Incorporated in
GB
Legal address
THE MOUND
EDINBURGH, EDH EH1 1YZ
GB
EDINBURGH, EDH EH1 1YZ
GB
Headquarters
33 OLD BROAD STREET
LONDON, LND EC2N 1HZ
GB
LONDON, LND EC2N 1HZ
GB
Valuation
Title GBP in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||